Recombinant might become a great healing alternative for adults with Adult Growth Hormone Deficiency (AGHD). Recent research indicates that many of the metabolic and psychosomatic abnormalities connected with HGH deficiency can be reversed with HGH therapy, even at low doses which are not connected with negative side effects.

results in many changes in body composition. Fat mass is condensed while lean body mass increases. The development in lean body mass is linked with increased protein mixture, muscle mass and muscle function. Whole body fat mass also reduced after six months of human growth hormone management. The reduction in fat mass is most noteworthy in visceral and trunk positions as compared to the arms, neck and legs, signifying that HGH therapy will reverse the redistribution of fat mass related with an adult growth hormone deficit and impact on cardiovascular risk.

Lipids may be improved by treating the patient with human growth hormones. There is research proving that brief courses of human growth hormone helped lower LDL cholesterol and this was associated with additional mRNA found in the liver's LDL receptor. One potential benefit of this association has not so far been studied with more extensive clinical trials. It must be said, however, that startling changes in serum lipid ratings is not always associated with treatments of human growth hormone.

will improve body composition, lipid metabolism, bone density, cardiovascular function and psychosomatic well being. Important issues remaining are the accurate clinical definition of partial vs. complete human growth hormone deficiency and clarifying the best tests to make this judgment. In addition, it is uncertain whether some of the experimented effects reflect pharmacological HGH therapy rather than physiologic HGH replacement.

Even so, it is plain to see that lower doses that are not related to a follow-up of HGH excess can be plenty to get the desired metabolic result. Research will show the perfect amount and what the long-term side effects of HGH therapy will be. These effects on cardiovascular morbidity and mortality are especially notable.

As we age our HGH levels reduce from what they were when we were younger. However, trying to keep the levels from a younger age has not yet proven beneficial. It is plausible that these age-related hormonal changes may be important and play a role in the aging process. This has not been clinically proven in people though. Hormone replacement therapy has been shown to have positive results. However, negative side effects such as increased risk for cancer, cardiovascular disease and behavioral changes may also happen.